President Donald Trump nominated Dr. Heidi Overton to be his new Food and Drug Administration commissioner. Dr. Overton is a White House domestic policy official who regularly briefs the President on various health issues. Dr. Overton would lead the agency if confirmed by the Senate. Most recently, she raised voiced concern about the Cyclospora outbreak and questioned the safety of the national food supply.
Will Humble, Executive Director of Arizona Public Health Association, joined “Arizona Horizon” to discuss what changes Dr. Overton may bring to the FDA.
Humble noted that it is important to note that the FDA is a regulatory agency and broke down some of the responsibilities that the head of the agency would have.
“The administrator of the FDA, is job is to look at the statues, look at the rules that the agency has created over decades, apply those rules to the regulatory work that they do. Whether that’s inspecting produce that comes in from from Mexico, or whether that is drugs, food, whether it is tobacco, cosmetics,” Humble said.
To take on this role of the commissioner, there are no concrete requirements for the role. However, Humble noted that Dr. Overton does have the academic knowledge and board certifications that would fit the background needed for this role. Although he went on add what he believes may be missing from Dr. Overton’s resume.
“The thing she is really missing in her resume is large scale management of, I mean, 16,000 people that work at the FDA. You are managing a really big regulatory infrastructure,” Humble said.
Humble also noted that he believes that her “worldview”, is another thing that may play into her decision making if she were to take on the commissioner role. He went on to saying that it is a “problem” when beliefs overshadows what the commissioner oversees in their work.



















